:::

詳目顯示

回上一頁
題名:Risk of Hyponatremia Induced by a Selective Serotonin Reuptake Inhibitor: A Care Report
書刊名:Taiwanese Journal of Psychiatry
作者:林聖祐高霈馨張鳳麟
作者(外文):Lin, Sheng-yuKao, Pei-hsinJang, Fong-lin
出版日期:2018
卷期:32:3
頁次:頁239-241
主題關鍵詞:血清素再回收抑制劑低鈉血症
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:9
期刊論文
1.Stahl, S. M.(2014)。Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic properties。CNS Spectr,19,207-212。  new window
2.De Picker, L.、Van Den Eede, F.、Dumont, G.、Moorkens, G.、Sabbe, B. G.(2014)。Antidepressants and the risk of hyponatremia: a class-by-class review of literature。Psychosomatics,55,536-547。  new window
3.Jacob, S.、Spinler, S. A.(2006)。Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults。Ann Pharmacother,40,1618-1622。  new window
4.Leth-Moller, K. B.、Hansen, A. H.、Torstensson, M.(2016)。Antidepressants and the risk of hyponatremia: a Danish register-based population study。BMJ Open,6,e011200。  new window
5.Varela, Pinon M.、Adan-Manes, J.(2017)。Selective serotonin reuptake inhibitor-induced hyponatremia: clinical implications and therapeutic alternatives。Clin Neuropharmacol,40,177-179。  new window
6.Mogi, T.、Yoshino, A.、Ikemoto, G.、Nomura, S.(2012)。Mirtazapine as an alternative for selective-serotoninreuptake-inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone。Psychiatry Clin Neurosci,66,80。  new window
7.Naranjo, C. A.、Busto, U.、Sellers, E. M.(1981)。A method for estimating the probability of adverse drug reactions。Clinical Pharmacology & Therapeutics,30,239-245。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關期刊論文
 
無相關博士論文
 
無相關書籍
 
無相關著作
 
QR Code
QRCODE